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In an attempt to improve the specificity of an enzyme-linked immunosorbent assay (ELISA) for the diagnosis
of paracoccidioidomycosis (PCM), sera from patients with PCM were tested using various approaches, such as
sodium metaperiodate antigen (gp43) treatment, a serum absorption process with Candida albicans or His-
toplasma capsulatum antigens, and dilution of serum in galactose, the main common epitope among pathogenic
fungi. The maximum specificity found in this ELISA was 84%. All of these procedures proved inefficient for
eliminating all cross-reacting antibodies and obtaining an ELISA specific for PCM diagnosis.
Paracoccidioidomycosis (PCM) is a mycotic disease caused
by the dimorphic fungus Paracoccidioides brasiliensis and
causes a deep mycosis, resulting in a severe chronic granulo-
matous infection of the skin, mucous membranes, lymph
nodes, and internal organs. Almost all South and Central
America countries have large regions where PCM is endemic.
The definitive diagnosis of PCM includes direct observation of
the characteristic multiple-budding cells in biological fluids
and tissue sections or isolation of the fungus from clinical
materials. For cases in which P. brasiliensis is not observed
through direct examination, several serological tests have been
used to detect antibodies against the fungus in order to estab-
lish the diagnosis (2). gp43, a 43,000-Da glycoprotein from P.
brasiliensis, is a major diagnostic antigen in serological assays
(1, 3, 15, 18, 23, 24). It has been demonstrated that gp43 is as
good as crude exoantigen preparations (concentrated, dialyzed
culture supernatants) (3, 4) for detecting precipitating anti-
body in immunodiffusion tests, and purified gp43 has also been
adapted to several other serological tests, such as immunopre-
cipitation of 125I-labeled gp43 (IPP), conventional enzyme-
linked immunosorbent assay (ELISA), capture enzyme immu-
noassay (EIA), and passive hemagglutination (5, 20, 23). Cross
reactivity in serological assays from patients with histoplasmo-
sis depends on the test used and seems to involve a carbohy-
drate epitope. While IPP and capture EIA using gp43 appear
specific for PCM diagnosis, experiments were performed to
determine the nature of the cross reactivity in sera from those
patients with histoplasmosis that reacted with gp43 in the IPP
tests. Treatment of gp43 with 0.2 M D-galactose inhibited such
cross reactivity, and no cross reactivity was observed with the
deglycosylated form of gp43, with EH38, or with the 38,000-Da
protein which had been treated with periodate (18). Owing to
the N-linked high-mannose nature of the gp43 glycan, degly-
cosylation was efficiently carried out with endo--N-acetylglu-
cosaminidase H. Since sera from patients with histoplasmosis
generally reacted with the high-molecular-weight glycocom-
plex present in the crude antigen of P. brasiliensis, this reac-
tivity and that with gp43 likely involved recognition of terminal
-galactofuranosyl units (24).
Travassos et al. (24) related that in general, specific reac-
tions with gp43 are obtained when the antigen is in solution,
such as in IPP, immunodiffusion, and immunoelectrophoresis,
and that fixing gp43 onto solid phase substrates, e.g., plastic,
increases the number of nonspecific reactions. The authors
also related that it is possible that the spatial distribution of the
gp43 glycan containing terminal -galactofuranosyl units when
fixed on a plastic substrate contributed to the increased acces-
sibility of these units to heterologous cross-reacting antibodies.
Mendes-Gianinni et al. (15) found that none of the sera
from patients with heterologous mycotic diseases reacted with
the gp43 in ELISA after sera had been absorbed once with a
culture filtrate of Histoplasma capsulatum. Similarly, Camargo
et al. (5) related the same phenomenon when they used het-
erologous sera preabsorbed with Candida albicans yeast cells.
However, contradicting results are found in the literature (17,
18).
ELISA has been employed in the serology of various mycotic
diseases (7, 10, 11, 12, 13, 21, 22). It is an extremely sensitive
method and is reagent saving compared with other assays. This
method can be automated and may be less time-consuming
and more economical for routine laboratories if specific reac-
tions could be obtained. However, it has important limitations
that arise from cross reactivity. Regarding the serology of
PCM, this fact has been well known since the first serological
studies using complement fixation tests, in the 1960s (8, 9). In
relation to the use of ELISA for PCM diagnosis, various stud-
ies have shown that the main problem presented by the use of
histoplasmosis sera is cross reaction (17, 18).
In this study, gp43 was assayed by ELISA, and we tried to
standardize specific ELISA for the diagnosis of PCM by using
various approaches. Then, gp43 was treated with sodium meta-
periodate in an attempt to abolish the carbohydrate epitopes
responsible for cross reactions; on the other hand, PCM and
histoplasmosis sera were previously absorbed with heterolo-
gous fungal antigens (H. capsulatum or C. albicans) in order to
eliminate cross-reactive antibodies; also, sera were diluted with
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galactose (0.2 M, final concentration) in order to eliminate
anti-galactose antibodies, the main P. brasiliensis epitope in
common with the H. capsulatum epitope (17), in an attempt to
obtain specific reactions for PCM. Finally, two assay proce-
dures were combined, absorption of sera with C. albicans and
H. capsulatum followed by dilution of sera in galactose.
Serum specimens from 25 patients with PCM were selected
on the basis of a positive direct examination of biological
fluids; 14 specimens from patients with proven acute histoplas-
mosis and 20 serum specimens from healthy individuals were
tested as controls in each scenario. All patient sera came from
Hospital Sa˜o Paulo, Sa˜o Paulo, Brazil. Gp43 was purified ac-
cording to the method of Puccia et al. (19), and optimization of
solid-phase gp43 antigen concentration was determined by a
peroxidase saturation technique (16). Once the ideal gp43 con-
centration to coat ELISA plates was determined, this molecule
was treated with sodium metaperiodate at 10, 20, and 40 mM
in order to determine the best concentration to eliminate car-
bohydrate epitopes without causing damage to the adsorbed
molecule.
Sera were absorbed first with whole mycelium of H. capsu-
latum, Alnara isolate, and second with C. albicans yeast cells
(ATCC 90028). Briefly, (i) 0.5 ml of serum was mixed with 0.5
ml of compacted C. albicans yeast cells and incubated under
rotatory slow movement for 2 h at 37°C and overnight at 4°C.
The mixture was then centrifuged at 2,000 rpm (10 min, 4°C),
and the supernatant was recovered. (ii) The same protocol was
used with compacted H. capsulatum mycelia. (iii) Sera were
absorbed with both antigens. (iv) Sera were diluted in galac-
tose (0.2 M, final concentration) in order to eliminate anti-
galactose antibody epitopes. (v) Sera were previously absorbed
with H. capsulatum and C. albicans followed by dilution in
galactose (0.2 M, final concentration). Flat 96-well polystyrene
plates were coated with gp43 in 0.1 M carbonate buffer [pH
9.6] and incubated for 1 h at 37°C and overnight at 4°C, fol-
lowed by an immunoenzymatic reaction (ELISA) according to
the method of Camargo et al. (5).
The ideal concentration of gp43 for coating the ELISA
plates and obtaining the best sensitivity was found to be 2.5
g/ml (250 ng/well). On the other hand, the treatment of gp43
with 40 mM sodium metaperiodate was found to be ideal in
order to obtain a better separation between homologous and
heterologous sera.
Figure 1 shows the overall results of ELISA using PCM and
histoplasmosis sera, before and after absorption processes, re-
acting against gp43 treated with 40 mM sodium metaperiodate.
First, Fig. 1A and B show the reactivity of sera from both
groups of patients reacting with treated gp43 before the ab-
sorption process. Sera from patients with PCM reacted with
the gp43 at dilutions of 1:3,200 to 1:102,400, and sera from
patients with histoplasmosis reacted at dilutions of 1:800 to
1:25,600. In this case, ELISA was specific for 84% of PCM
sera. As shown in Fig. 1C, when both groups of sera were
absorbed with C. albicans, sera from patients with PCM re-
acted at dilutions of 1:200 to 1:51,200, and sera from patients
with histoplasmosis reacted at dilutions of 1:400 to 1:12,800,
indicating a 68% specificity of ELISA for PCM. As shown in
Fig. 1D, when both groups of sera were absorbed with H.
capsulatum antigen, sera from patients with PCM reacted at
dilutions of 1:100 to 1:25,600 and sera from patients with
histoplasmosis reacted at dilutions of 1:100 to 1:800, indicating
a specificity of 80%. Similarly, as shown in Fig. 1E, when sera
were diluted only in 0.2 M galactose, PCM sera reacted at
dilutions of 1:100 to 1:51,200, and sera from histoplasmosis
patients reacted at dilutions of 1:400 to 1:12800, showing a
specificity of 60%. Figure 1F shows the reactivity of both
groups of sera which were absorbed first with C. albicans, and
then absorbed with H. capsulatum, and finally diluted in 0.2 M
galactose. In this case, the specificity of ELISA was about 68%.
Note that control sera from healthy individuals reacted in each
FIG. 1. Results of ELISAs using PCM and histoplasmosis sera, before and after absorption processes. A and B, sera from both groups of
patients reacting with gp43, before and after treatment with 40 mM sodium metaperiodate; C, patient sera absorbed with C. albicans; D, patient
sera absorbed with H. capsulatum; E, patient sera diluted with galactose; F, patient sera absorbed with C. albicans and H. capsulatum antigens and
diluted in galactose.
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scenario until the 1:200 dilution. All ELISAs were repeated at
least three times with good reproducibility.
Nowadays, ELISA is a very popular test for the detection
and quantitation of antibodies in medical research and in the
clinical laboratory. In general, ELISA has a high sensitivity, but
that sensitivity is not necessarily coupled with high specificity.
For many years, ELISA has been the subject of many publi-
cations about antibody detection in many fungal diseases,
mainly PCM (2, 6, 7, 10, 11, 12, 13, 21, 22). In this context, it
has been used with a range of different kinds of antigenic
preparations, such as crude mixtures (exoantigens and cyto-
plasmic antigens), partially purified preparations, and purified
molecule, such as gp43. However, in a series of studies on PCM
serology, and even in our previous paper (5), the authors de-
scribed how a previous serum absorption process can eliminate
antibodies responsible for cross reactivity (5, 14). During many
years of experience in serology of PCM, however, we have
observed that it is very difficult to obtain specific ELISA results
and that many results are not reproducible. Sometimes, in some
lots of PCM sera, we can obtain good differentiation between
homologous and heterologous sera; at other times, these results
are not obtained. This instability of results leads us to think that
other factors, e.g., individual characteristics of each serum, the P.
brasiliensis isolate that caused the disease, the individual immune
response against a specific isolate that may carry different
antigenic epitopes, are influencing the reactions.
In general, sodium metaperiodate can partially eliminate
carbohydrate epitopes responsible for cross reactions and then
may increase the specificity of the reaction; also, the absorp-
tion process with heterologous fungus cells may lead to a better
specificity by eliminating common antibodies responsible for
the cross reactivity.
In an attempt to obtain specific ELISA reactions for the
diagnosis of PCM, we tried to use purified gp43 antigen, the
immunodominant molecule which is specific when used in im-
munodiffusion tests, treated with sodium metaperiodate and
sera individually preabsorbed with C. albicans or H. capsula-
tum or simultaneously absorbed with both antigens or sera
diluted with galactose, the main cross-reacted carbohydrate.
On the other hand, completely specific results were not ob-
tained with tests of the C. albicans and H. capsulatum serum
absorption processes followed by dilution of sera in galactose
or by EIA reactivity tests with gp43 metaperiodate treatment.
Although gp43 is firmly established as a specific molecule for
the serological diagnosis of PCM, this specificity depends on the
test used, such as immunodiffusion. However, only a thorough
understanding of its structure allows us to develop other ap-
proaches in order to obtain specific results by means of ELISA.
In conclusion, we related here the difficulty in obtaining an
ELISA for specific and definitive diagnosis of PCM, even after
treatment of gp43 with metaperiodate and the absorption pro-
cess. These kinds of results lead us to reflect on how difficult it
is to work in this area and to try to find new procedures to
achieve our objectives.
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